Last update 01 Nov 2024

Arisyn Therapeutics Inc

2008

Overview

Related

15
Drugs associated with Arisyn Therapeutics Inc
9-Aminocamptothecin
Target
TOP1
Mechanism
TOP1 inhibitors
Active Org.-
Originator Org.
Arisyn Therapeutics Inc
Active Indication-
Inactive Indication
Advanced Lung Non-Small Cell Carcinoma [+10]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Lucanthone
Target
APE1 x Top II
Mechanism
APE1 inhibitors [+1]
Active Org.-
Originator Org.
Arisyn Therapeutics Inc
Active Indication-
Inactive Indication
Brain Cancer [+4]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Pipoxazole
Target
adrenergic receptor
Mechanism
adrenergic receptor agonists
Active Org.-
Originator Org.
Arisyn Therapeutics Inc
Active Indication-
Inactive Indication
Depressive Disorder [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Arisyn Therapeutics Inc
Login to view more data
0 Patents (Medical) associated with Arisyn Therapeutics Inc
Login to view more data
100 Deals associated with Arisyn Therapeutics Inc
Login to view more data
100 Translational Medicine associated with Arisyn Therapeutics Inc
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
15
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pipoxazole
 ( adrenergic receptor )		Depressive Disorder
More
Discontinued
Lucanthone
 ( APE1 x Top II )		Brain Cancer
More
Discontinued
Beta Lapachone
 ( NQO1 )		Leiomyoma
More
Discontinued
GM-1485
 ( FKBP )		Erectile Dysfunction
More
Discontinued
Asulacrine Isethionate
 ( Top II )		Neoplasms
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free